Premium
Outcomes in occupational asthma caused by reactive dye after long‐term avoidance
Author(s) -
Park H. W.,
Kim D. I.,
Sohn S. W.,
Park C. H.,
Kim S. S.,
Chang Y. S.,
Min K. U.,
Kim Y. Y.,
Cho S. H.
Publication year - 2007
Publication title -
clinical and experimental allergy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.462
H-Index - 154
eISSN - 1365-2222
pISSN - 0954-7894
DOI - 10.1111/j.1365-2222.2007.02641.x
Subject(s) - medicine , methacholine , asthma , provocation test , eosinophilia , sputum , occupational asthma , bronchial hyperresponsiveness , intoxicative inhalant , allergy , airway , aeroallergen , pulmonary function testing , corticosteroid , spirometry , allergen , immunology , lung , anesthesia , respiratory disease , pathology , tuberculosis , toxicology , alternative medicine , biology
Summary Background Reactive dye (RD) is known to be a causative agent of occupational asthma (OA). However, to date, no report has been issued concerning the long‐term outcomes of RD‐induced OA. Objectives We sought to evaluate the long‐term outcomes in cases of OA caused by RD. Methods A total of 11 OA patients confirmed by RD bronchial challenge were enrolled in this study. First and second follow‐up examinations were conducted at 4.3±2.3 and 13.7±2.3 years (means±SD) after the initial examinations, respectively. Skin prick test with RD and 11 common inhalant allergens, pulmonary function test, methacholine bronchial provocation testing, symptom and medication scores were determined at each visit. In addition, inflammatory cells in induced sputum were measured at the second follow‐up examinations. Results Reduced lung function at initial examinations did not recover at the first and second examinations despite cessation of exposure and proper pharmacological treatment. In addition, asthma severity (as determined by symptom and medication scores) and non‐specific airway hyper‐responsiveness to methacholine also did not improve. However, skin reactivity to RD almost disappeared at the second examinations. Interestingly, four of the six patients who showed negative skin responses to all 11 common inhalant allergens at initial examinations were found to be atopic at the second examinations. Moreover, in terms of airway inflammation, seven of the 11 patients showed eosinophilia in induced sputum (3%) at the second examinations despite having been on high‐dose inhaled corticosteroid medication. Conclusion The present study demonstrates that reduced lung function and asthmatic symptoms persist in RD‐induced OA even after long‐term exposure avoidance.